| Name | Title | Contact Details |
|---|
Maryland Physicians Care is a Windsor Mill, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
For over 33 years, AultCare has been an industry leader in a competitive health care market. Through innovative plan designs, superior customer service and a cost effective, high quality network, AultCare has continued to keep enrollees and clients satisfied while remaining committed to providing affordable health care options. Throughout the years, AultCare has grown to become a valuable asset to our community. AultCare keeps costs lower than other areas in Ohio through our effective, high quality network. Our margins are smaller than national plans because we have accountability to our local community of individuals and employers. During our 30 years as an organization, teamwork has been a steadfast theme and it continues to remain an integral principle in our culture of nearly 500 employees. The unity of our teamwork has allowed us to be at the forefront for offering efficient health care to our community. Additionally, our commitment to teamwork has helped us provide excellent customer service, quality, and cost effective health care planning, which is at the standard core of our philosophy. Superior customer service is also an integral part of our daily business interactions. Due to the complexity of the health care industry, questions from members and employers may arise. All of our employees strive to provide an extra, personalized touch through all member interactions, whether over the phone or in person. AultCare brings a value to health care that is unparalleled in the market. As we continue to evolve, AultCare will welcome your feedback, strive to maintain our position as a steadfast leader in the health care industry, and be proud to serve you.
Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs. The company has assembled an experienced team along with a portfolio of clinical and commercial stage programs with the goal of bringing important new treatment options to patients.
AcelRx Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. The Company`s product candidates, DSUVIA™ (known as ARX-04 outside of the United States) and ZALVISO®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. DSUVIA is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. The Phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. In clinical studies, DSUVIA demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and vomiting. A New Drug Application (NDA) was filed with the FDA in December 2016. ZALVISO is designed to deliver sublingual tablets containing 15 mcg sufentanil via a novel hand-held, pre-programmed, patient-controlled analgesia system. Three Phase 3 clinical trials have been completed in patients who had undergone major abdominal or orthopedic surgeries. A fourth study (IAP312) is underway to further evaluate the overall performance of the ZALVISO System in post-surgical patients. ZALVISO is currently approved by the European Commission for the management of acute moderate-to-severe post-operative pain in adult patients in a hospital setting, and is marketed by Grünenthal Group, AcelRx`s licensee in Europe and Australia. In the United States and other geographies, ZALVISO remains an investigational product.
Stockamp delivers: Stockamp helps high-performing hospitals reach the pinnacle of financial and operational excellence. We invented and perfected the science of revenue cycle management for hospitals and health systems, based on our unmatched